Skip to main content

22-431 Offer Patients Added Treatment Options for COVID-19 with Oral Antivirals

June 10, 2022

This information applies to Physicians and Independent Practice Associations.

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.

This flyer shares information about two COVID-19 oral antiviral medications – PaxlovidTM and LagevrioTM. These are available by prescription only to individuals who qualify, have mild to moderate COVID-19 symptoms and who are at high risk.

Download the provider updateEste documento PDF se abrirá en una ventana nueva.

Ícono de Contact Us (Comuníquese con nosotros)

¿Necesita ayuda? Puede contar con nosotros.

Comuníquese con nosotros
Last Updated On: 8/12/2024
On Feb. 21, 2024, Change Healthcare experienced a cyber security incident. Any individuals impacted by this incident will receive a letter in the mail. Learn more about this from Change Healthcare, or reach out to the contact center at 1-866-262-5342. ×